GMO
Deep Value Still Cheap
GMO argues international deep value equities remain one of the most compelling opportunities globally, despite strong recent performance, as valuation gaps versus the U.S. stay historically wide.
GMO’s deep value strategy trades at...
2026-05-01
2026-05-01
Morgan Stanley
Energy Shock Meets AI Rotation
Morgan Stanley Investment Management argues markets are navigating two overlapping shocks—an energy supply crisis and a rapid AI-driven rotation—creating unusual sector dynamics and fragile sentiment.
Brent crude surged 6...
2026-05-01
Amundi Asset Managers
Europe’s Pension Shift: From Fiscal Burden to Capital Market Engine
Amundi argues Europe’s pension transformation is no longer just a demographic problem, but a structural shift that could reshape capital markets by mobilising long-term savings.
Ageing populations, fiscal constraints, and the shift...
2026-05-01
Amundi Asset Managers
Europe’s Pension Shift: From Fiscal Burden to Capital Market Engine
Amundi argues Europe’s pension transformation is no longer just a demographic problem, but a structural shift that could reshape capital markets by mobilising long-term savings.
Ageing populations, fiscal constraints, and the shift...
2026-04-30
Allianz Global Investors
China’s Growth Engine Still Runs on Exports and Investment
AllianzGI argues China’s 2026 outlook remains resilient, but growth is still powered by manufacturing, exports and state-backed investment rather than household consumption.
AllianzGI expects 4.8% GDP growth in 2026, versu...
2026-04-30
BlackRock/iShares
Persistent Inflation Leaves Central Banks Trapped
BlackRock says inflation pressures were already entrenched before the Middle East supply shock, leaving policymakers with little room to support growth.
Markets have rapidly priced out U.S. rate cuts in 2026 as energy and input costs rise...
2026-04-30
Van Lanschot Kempen
Farmland’s Inflation Hedge Is Uneven—but Real
Kempen argues the shift toward structurally higher inflation strengthens the long-term case for farmland, even if short-term operating pressures can be painful.
Near term, margins can be squeezed by higher energy, fertiliser and labo...
2026-04-30
Legal & General Investment Management
Adapting to Uncertainty: L&G Stays Pro-Risk but More Selective
Legal & General’s Q2 2026 outlook argues investors should adapt to a world of persistent geopolitical and inflation shocks, favouring equities while becoming more cautious on credit and duration.
L&G upgraded equities t...
2026-04-29
Schroders
The $1 Trillion Hunt for UK Biotech
Schroders says a looming pharmaceutical patent cliff and scarce venture capital are creating a potentially major opportunity in UK biotech.
Big Pharma faces $67 billion in projected patent-expiry revenue losses by 2029.
The in...
2026-04-29
Nuveen
High Yield Bonds: The Quiet Winner in a Noisy Market
Nuveen argues that while investors focus on equities and geopolitics, U.S. high yield credit offers an overlooked mix of income, improving quality, and limited AI disruption risk.
U.S. high yield returned +1.30% YTD through 21 A...
